Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 198

1.

[CAPNETZ. The competence network for community-acquired pneumonia (CAP)].

Suttorp N, Welte T, Marre R, Stenger S, Pletz M, Rupp J, Schütte H, Rohde G; CAPNETZ-Studiengruppe.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Apr;59(4):475-81. doi: 10.1007/s00103-016-2318-7. German.

PMID:
26984399
2.

Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia.

Ewig S, Hecker H, Suttorp N, Marre R, Welte T; CAPNETZ study group.

J Infect. 2011 Mar;62(3):218-25. doi: 10.1016/j.jinf.2011.01.009. Epub 2011 Jan 27.

PMID:
21276814
3.

How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.

von Baum H, Schweiger B, Welte T, Marre R, Suttorp N, Pletz MW, Ewig S; CAPNETZ Study Group.

Eur Respir J. 2011 May;37(5):1151-7. doi: 10.1183/09031936.00037410. Epub 2010 Sep 3.

4.
5.

Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ.

Krüger S, Ewig S, Kunde J, Hartmann O, Marre R, Suttorp N, Welte T; CAPNETZ study group.

Clin Chim Acta. 2010 Dec 14;411(23-24):1929-34. doi: 10.1016/j.cca.2010.08.004. Epub 2010 Aug 7.

PMID:
20699094
6.

Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia.

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H; Paul-Ehrlich-Society of Chemotherapy; German Respiratory Diseases Society; German Infectious Diseases Society; Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia.

Pneumologie. 2010 Mar;64(3):149-54. doi: 10.1055/s-0029-1243910. Epub 2010 Feb 23. No abstract available.

7.

[Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults].

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H.

Dtsch Med Wochenschr. 2010 Feb;135(8):359-65. doi: 10.1055/s-0030-1249171. Epub 2010 Feb 17. German. No abstract available.

PMID:
20166002
8.

[Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany].

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H; Paul-Ehrlich-Gesellschaft für Chemotherapie; Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin; Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ.

Pneumologie. 2009 Oct;63(10):e1-68. doi: 10.1055/s-0029-1215037. Epub 2009 Oct 9. German. No abstract available.

9.

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors.

von Baum H, Welte T, Marre R, Suttorp N, Ewig S; CAPNETZ study group.

Eur Respir J. 2010 Mar;35(3):598-605. doi: 10.1183/09031936.00091809. Epub 2009 Aug 13.

10.

Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Krüger S, Ewig S, Papassotiriou J, Kunde J, Marre R, von Baum H, Suttor N, Welte T; CAPNETZ Study Group.

Respir Res. 2009 Jul 12;10:65. doi: 10.1186/1465-9921-10-65.

11.

Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

von Baum H, Welte T, Marre R, Suttorp N, Lück C, Ewig S.

BMC Infect Dis. 2009 May 13;9:62. doi: 10.1186/1471-2334-9-62.

12.

C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.

Krüger S, Ewig S, Kunde J, Hanschmann A, Marre R, Suttorp N, Welte T; CAPNETZ Study Group.

J Antimicrob Chemother. 2009 Jul;64(1):159-62. doi: 10.1093/jac/dkp148. Epub 2009 Apr 29.

PMID:
19403654
13.

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

Tessmer A, Welte T, Martus P, Schnoor M, Marre R, Suttorp N.

J Antimicrob Chemother. 2009 May;63(5):1025-33. doi: 10.1093/jac/dkp088. Epub 2009 Mar 17.

PMID:
19293196
14.
15.

Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia.

von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Lück C; Competence Network for Community Acquired Pneumonia Study Group.

Clin Infect Dis. 2008 May 1;46(9):1356-64. doi: 10.1086/586741.

PMID:
18419436
16.

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment.

Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K; Competence Network for Community-Acquired Pneumonia study group.

Eur Respir J. 2008 Jul;32(1):139-46. doi: 10.1183/09031936.00092507. Epub 2008 Feb 20.

17.

Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany.

Raum E, Lietzau S, von Baum H, Marre R, Brenner H.

Clin Microbiol Infect. 2008 Jan;14(1):41-8. Epub 2007 Nov 13.

18.

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.

Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group.

Eur Respir J. 2008 Feb;31(2):349-55. Epub 2007 Oct 24.

19.

[Interobserver agreement in the assessment of pulmonary infiltrates on chest radiography in community-acquired pneumonia].

Pauls S, Krüger S, Richter K, Muche R, Marre R, Welte T, Billich C, Gonschior S, Schumann C, Boll D, Aschoff AJ, Suttorp N.

Rofo. 2007 Nov;179(11):1152-8. German.

PMID:
17948193
20.

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T; CAPNETZ Study Group.

Intensive Care Med. 2007 Dec;33(12):2069-78. Epub 2007 Oct 16.

PMID:
17938883

Supplemental Content

Loading ...
Support Center